Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
Ciprofloxacin versus Aminoglycoside-Ciprofloxacin for Bubonic Plague.
Randremanana RV. et al, (2025), The New England journal of medicine, 393, 544 - 555
Sotrovimab versus usual care in patients admitted to hospital with COVID-19: a randomised, controlled, open-label, platform trial (RECOVERY)
HORBY P. et al, (2025), The Lancet Infectious Diseases
Vaccine effects on in-hospital COVID-19 outcomes.
Gonçalves BP. et al, (2025), Epidemiology (Cambridge, Mass.)
Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19: a randomised, controlled, open-label, platform trial (RECOVERY)
HORBY PW. et al, (2025), The Lancet Infectious Diseases
Tecovirimat for Clade I MPXV Infection in the Democratic Republic of Congo.
PALM007 Writing Group None. et al, (2025), N Engl J Med, 392, 1484 - 1496
Detection of mpox and other orthopoxviruses using a lateral flow device as a point-of-care diagnostic.
Laidlaw SM. et al, (2025), Microbiology spectrum, 13
‘Involve those who are managing these outbreaks’: stakeholders’ perspectives on the barriers and facilitators to the implementation of clinical management guidelines for high-consequence infectious diseases in Uganda—a thematic network analysis
Kabajaasi O. et al, (2025), BMJ Public Health, 3, e001165 - e001165
Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics
Bourner J. et al, (2025), Emerging Infectious Diseases, 31
Europe needs a sustainably funded influenza research and response network.
Krammer F. et al, (2025), The Lancet. Infectious diseases
Improving clinical care of patients in Nipah outbreaks: moving beyond 'compassionate use'.
Hassan MZ. et al, (2025), The Lancet regional health. Southeast Asia, 33
Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational study
Kasbergen LMR. et al, (2025), The Lancet Infectious Diseases
Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational study
Sigfrid L. et al, (2025), The Lancet Infectious Diseases
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
HAYNES R. et al, (2025), EClinicalMedicine
Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC).
Pesonel E. et al, (2025), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
The Lancet Infectious Diseases Series on the Modern Landscape of Ebola: Bridging Scientific Discoveries and Clinical Application
ROJEK A. et al, (2024), The Lancet Infectious Diseases
Ebola disease: bridging scientific discoveries and clinical application.
Rojek A. et al, (2024), The Lancet. Infectious diseases
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials
Chan XHS. et al, (2024), The Lancet Microbe, 101002 - 101002